Epitalon is the tetrapeptide Ala-Glu-Asp-Gly (AEDG), studied as a reagent in cellular-aging research
PHASE 1 SAFETY AND TOLERABILITY STUDY OF IMB-1018972, A NOVEL ORAL MODULATOR OF MYOCARDIAL SUBSTRATE UTILIZATION DESIGNED TO IMPROVE CARDIAC METABOLIC EFFICIENCY AND BIOENERGETICS
Researchers have documented the safety profile observed in published Phase 2 research as predominantly gastrointestinal effects (nausea, diarrhoea, vomiting) typical of the incretin class, occurring most prominently during dose escalation and tending to decline with continued exposure (PMID 39515565, PMID 41785010)
Prep your patients so they dont panic and drop out before seeing results
Burmeister MA, Brown JD, Ayala JE, Stoffers DA, Sandoval DA, Seeley RJ, et al
The drugs come in standard doses